Status:
UNKNOWN
Physiotherapy in Hypoxic AECOPD Patients
Lead Sponsor:
Universidad de Granada
Conditions:
COPD Exacerbation
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Hypoxia is considered a key player in many of the comorbidities that characterize COPD, such as pulmonary hypertension, skeletal muscle dysfunction, and systemic inflammation. These comorbidities are ...
Eligibility Criteria
Inclusion
- Patients of both sexes
- A diagnosis of COPD made according to the criteria of the American Thoracic Society (ATS)
- With hypoxemia at rest defined as mean arterial oxygen saturation below 90%
- Agreed to participate
Exclusion
- Unstable cardiovascular disease
- Orthopedic diseases in the upper and lower limbs
- Being in ICU or use of mechanical ventilation
- Motor sequelae from a neurological or cognitive impairment that interfere with the evaluation and the treatment
- Contraindications of electrotherapy
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04295655
Start Date
December 1 2019
End Date
April 1 2020
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Health Sciences. University of Granada.
Granada, Granada, Spain, 18071